Lineage Cell Therapeutics In shares owned by Geode Capital Management
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Geode Capital Management
from 13F filings
Historical chart of Geode Capital Management investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Geode Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.1M | 2.4M | 1.69 |
| 2025-06-30 | $2.2M | 2.4M | 0.91 |
| 2025-03-31 | $2.0M | 4.5M | 0.45 |
| 2024-12-31 | $1.9M | 3.7M | 0.50 |
| 2024-09-30 | $3.3M | 3.7M | 0.91 |
| 2024-06-30 | $3.6M | 3.6M | 1.00 |
| 2024-03-31 | $4.8M | 3.3M | 1.48 |
| 2023-09-30 | $3.3M | 2.8M | 1.18 |
| 2023-06-30 | $3.4M | 2.4M | 1.41 |
| 2023-03-31 | $1.9M | 1.3M | 1.50 |
| 2022-12-31 | $1.5M | 1.3M | 1.17 |
| 2022-09-30 | $1.4M | 1.3M | 1.13 |
| 2022-06-30 | $2.0M | 1.2M | 1.58 |
| 2022-03-31 | $3.5M | 2.3M | 1.54 |
| 2021-12-31 | $5.7M | 2.3M | 2.45 |
| 2021-09-30 | $5.9M | 2.3M | 2.52 |
| 2021-06-30 | $6.7M | 2.3M | 2.85 |
| 2021-03-31 | $3.0M | 1.3M | 2.35 |
| 2020-12-31 | $1.9M | 1.1M | 1.76 |
| 2020-09-30 | $956k | 1.0M | 0.94 |
| 2020-06-30 | $888k | 1.0M | 0.87 |
| 2020-03-31 | $1.4M | 1.7M | 0.83 |
| 2019-12-31 | $1.4M | 1.6M | 0.89 |
| 2019-09-30 | $1.5M | 1.5M | 0.98 |